Reduction of Cardiovascular Risk Using Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Patients With Acute Coronary Syndrome: A Systematic Review

Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a hepatic enzyme that regulates blood cholesterol levels by degrading low-density lipoprotein (LDL) receptors from the surface of hepatocytes. Studies have shown that inhibiting this molecule decreases the cardiovascular risk in individuals wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Rabih, Ahmad M, Niaj, Ahmad, Raman, Aishwarya, Uprety, Manish, Calero, Maria Jose, Villanueva, Maria Resah B, Joshaghani, Narges, Villa, Nicole, Badla, Omar, Goit, Raman, Saddik, Samia E, Dawood, Sarah N, Mohammed, Lubna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990958/
https://www.ncbi.nlm.nih.gov/pubmed/36895542
http://dx.doi.org/10.7759/cureus.34648

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990958/
https://www.ncbi.nlm.nih.gov/pubmed/36895542
http://dx.doi.org/10.7759/cureus.34648

Ejemplares similares